
    
      To test the hypothesis that inhibition of I [kappa] B kinase [beta] (IĸKβ), an inflammatory
      mediator, by high dose salsalate, will restore insulin-mediated endothelium-dependent
      vasodilation in subjects with atherosclerosis.
    
  